BioGend Therapeutics Co., Ltd. (TPEX:6733)
Taiwan · Delayed Price · Currency is TWD 20.40
-0.15 (-0.73%)
Nov 13, 2026, 1:30 PM CST
BioGend Therapeutics Market Cap
BioGend Therapeutics has a market cap or net worth of 2.74 billion as of November 13, 2026. It is the 26,269th most valuable company in the world and the 1,432nd biggest in Taiwan. Its market cap has decreased by 43.28% in one year.
Market Cap
2.74B
Enterprise Value
1.93B
Revenue
235.24M
Global Rank
Country Rank
#1,432 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since June 18, 2019, BioGend Therapeutics's market cap has increased from 2.71B to 2.74B, an increase of 0.95%. That is a compound annual growth rate of 0.13%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 2.74B | -42.62% |
| Dec 31, 2025 | 4.78B | 14.21% |
| Dec 31, 2024 | 4.18B | -11.18% |
| Dec 29, 2023 | 4.71B | 109.50% |
| Dec 30, 2022 | 2.25B | -18.50% |
| Dec 30, 2021 | 2.76B | -22.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SYN-TECH Chem. & Pharm. | 3.39B |
| Pharmosa Biopharm | 3.28B |
| Formosa Pharmaceuticals | 3.13B |
| Great Novel Therapeutics Biotech & Medicals | 3.07B |
| Sagittarius Life Science | 3.00B |
| Shine-On BioMedical | 2.96B |
| Intech Biopharm | 2.74B |
| Senhwa Biosciences | 2.65B |